IP Library Granted Patent US 10,386,321
Granted Patent B2
US 10,386,321 · App. 15/503,364 · Granted Aug 20, 2019

Noninvasive body fluid stress sensing

Inventors: Jeffrey LaBelle (Tempe, AZ); Tina Hakimi (Phoenix, AZ); Brittney Cardinell (Chandler, AZ)
Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
G01N27/327A61B5/14507A61B5/14546G01N27/026G01N27/301G01N27/3273G01N33/5436G01N33/5438G01N33/743A61B5/053A61B5/165A61B2562/0215G01N2800/7004
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,386,321
App. No.
15/503,364
Granted
Aug 20, 2019
Kind
B2
Abstract

Electrochemical impedance-based label-free and rapid biosensor for select bodily fluid biomolecule levels. Monoclonal antibodies to of biomolecule such as Cortisol were covalently attached to a 16-mercaptohexadecanoic acid functionalized gold working electrode using zero-length crosslinkers N-(3-dimethylaminopropyl)-N-ethylcarbodiimide and 10 mM N-hydroxysulfosuccinimide. Cortisol was detected in phosphate buffered saline (simulated tear fluid) using a simple ferrocyanide reagent with a lower limit of detection of 18.73 pM and less than 10% relative standard deviation.

Claims (12)

1. An electrochemical sensor, comprising:

a reference electrode and a counter electrode;

a sensing well disposed between said reference electrode and said counter electrode; and

a functionalized working electrode encapsulated in a mesoporous carbon ink and disposed within said sensing well; wherein

one or more of a molecular recognition unit to a stress marker is coupled to said functionalized working electrode.

2. The sensor of claim 1 , wherein said one or more molecular recognition units comprise monoclonal antibodies are covalently attached to a 16-mercaptohexadecanoic acid functionalized working electrode.

3. The sensor of claim 2 , wherein said one or more monoclonal antibodies are attached to said functionalized working electrode with zero-length crosslinkers N-(3-dimethylaminopropyl}-N-ethylcarbodiimide and 1 OmM N-hydroxysulfosuccinimide.

4. The sensor of claim 3 , wherein said reference electrode comprises a Ag/AgCl electrode.

5. The sensor of claim 4 , wherein said counter electrode comprises a Pt electrode.

6. The sensor of claim 1 , further comprising a multiplexible electrochemical impedance spectroscopy system in operable arrangement therewith.

7. The sensor of claim 1 , wherein said reference electrode and said counter electrode are disposed both within and outside of said sensing well.

8. The sensor of claim 1 , wherein said reference electrode and said counter electrode are disposed along a sidewall within said sensing well.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2017
From: LABELLE, JEFFREY; HAKIMI, TINA; HASELWOOD, BRITTNEY
To: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
Reel/Frame 041230/0516 →
Continuity (3)
Provisional Application 62037006 · Aug 13, 2014
Provisional Application 62101143 · Jan 8, 2015
Related Publication 20170234894A1 · Aug 17, 2017